|
1
|
Stang A, Trabert B, Wentzensen N, Cook MB,
Rusner C, Oosterhuis JW and McGlynn KA: Gonadal and extragonadal
germ cell tumors in the United States, 1973–2007. Int J Androl.
35:616–625. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Albany C and Einhorn LH: Extragonadal germ
cell tumors: Clinical presentation and management. Curr Opin Oncol.
25:261–265. 2013.PubMed/NCBI
|
|
3
|
Schmoll HJ: Extragonadal germ cell tumors.
Ann Oncol. 13:(Suppl 4). 265–272. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McKenney JK, Heerema-McKenney A and Rouse
RV: Extragonadal germ cell tumors: A review with emphasis on
pathologic features, clinical prognostic variables, and
differential diagnostic considerations. Adv Anat Pathol. 14:69–92.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Toner GC, Geller NL, Lin SY and Bosl GJ:
Extragonadal and poor risk nonseminomatous germ cell tumors.
Survival and prognostic features. Cancer. 67:2049–2057. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rodney AJ, Tannir NM, Siefker-Radtke AO,
Liu P, Walsh GL, Millikan RE, Swisher SG, Tu SM and Pagliaro LC:
Survival outcomes for men with mediastinal germ-cell tumors: The
university of Texas M. D. Anderson cancer center experience. Urol
Oncol. 30:879–885. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Talerman A: Endodermal sinus (yolk sac)
tumor elements in testicular germ-cell tumors in adults: Comparison
of prospective and retrospective studies. Cancer. 46:1213–1217.
1980. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Motzer RJ, Geller NL, Tan CC, Herr H,
Morse M, Fair W, Sheinfeld J, Sogani P, Russo P and Bosl GJ:
Salvage chemotherapy for patients with germ cell tumors: The
memorial Sloan-Kettering cancer center experience (1979–1989).
Cancer. 67:1305–1310. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kondagunta GV, Bacik J, Sheinfeld J,
Bajorin D, Bains M, Reich L, Deluca J, Budnick A, Ishill N,
Mazumdar M, et al: Paclitaxel plus ifosfamide followed by high-dose
carboplatin plus etoposide in previously treated germ cell tumors.
J Clin Oncol. 25:85–90. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rittiluechai K, Wilcox R, Lisle J, Everett
E, Wallace HJ III and Verschraegen CF: Prognosis of hepatoid yolk
sac tumor in women: What's up, Doc? Eur J Obstet Gynecol Reprod
Biol. 175:25–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shah JP, Kumar S, Bryant CS, Ali-Fehmi R,
Malone JM Jr, Deppe G and Morris RT: A population-based analysis of
788 cases of yolk sac tumors: A comparison of males and females.
Int J Cancer. 123:2671–2675. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pelosi G, Petrella F, Sandri MT, Spaggiari
L, Galetta D and Viale G: A primary pure yolk sac tumor of the lung
exhibiting CDX-2 immunoreactivity and increased serum levels of
alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol.
14:247–251. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang B, Gao S, Chen Y and Wu Y: Primary
yolk sac tumor arising in the pancreas with hepatic metastasis: A
case report. Korean J Radiol. 11:472–475. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kumar Y, Bhatia A, Kumar V and Vaiphei K:
Intrarenal pure yolk sac tumor: An extremely rare entity. Int J
Surg Pathol. 15:204–206. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Guzel A, Tatli M, Belen D and Seckin H:
Spinal cord compression of primary extragonadal giant yolk sac
tumor. Spinal Cord. 45:254–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Takahashi T, Ishikawa E, Masuda Y,
Yamamoto T, Sato T, Shibuya M and Matsumura A: Mixed germ cell
tumor with extensive yolk sac tumor elements in the frontal lobe of
an adult. Case Rep Surg. 2012:4737902012.PubMed/NCBI
|
|
17
|
Ueno T, Tanaka YO, Nagata M, Tsunoda H,
Anno I, Ishikawa S, Kawai K and Itai Y: Spectrum of germ cell
tumors: From head to toe. Radiographics. 24:387–404. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan Z, van de Rijn M, Montgomery K and
Rouse RV: Hep par 1 antibody stain for the differential diagnosis
of hepatocellular carcinoma: 676 tumors tested using tissue
microarrays and conventional tissue sections. Mod Pathol.
16:137–144. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su JS, Chen YT, Wang RC, Wu CY, Lee SW and
Lee TY: Clinicopathological characteristics in the differential
diagnosis of hepatoid adenocarcinoma: A literature review. World J
Gastroenterol. 19:321–327. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Choi HJ, Cho BC, Sohn JH, Shin SJ, Kim SH,
Kim JH and Yoo NC: Brain metastases from hepatocellular carcinoma:
Prognostic factors and outcome: Brain metastasis from HCC. J
Neurooncol. 91:307–313. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Moran CA and Suster S: Hepatoid yolk sac
tumors of the mediastinum: A clinicopathologic and
immunohistochemical study of four cases. Am J Surg Pathol.
21:1210–1214. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Horie Y and Kato M: Hepatoid variant of
yolk sac tumor of the testis. Pathol Int. 50:754–558. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Schmoll HJ, Souchon R, Krege S, Albers P,
Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R,
Fizazi K, et al: European consensus on diagnosis and treatment of
germ cell cancer: A report of the European germ cell cancer
consensus group (EGCCCG). Ann Oncol. 15:1377–1399. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Packer RJ, Cohen BH and Cooney K:
Intracranial germ cell tumors. Oncologist. 5:312–320.
2000.PubMed/NCBI
|
